News
SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...
Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
AGM/EGM/MiscellaneousOrdinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities 18.06.2025 / 16:43 CET/CESTThe issuer is solely responsible for the content of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback